Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009, Article ID 310132, 6 pages
http://dx.doi.org/10.1155/2009/310132
Review Article

Eosinophils and Oral Squamous Cell Carcinoma: A Short Review

Laboratory of Oral and Maxillofacial Pathology, Division of Stomatology and Oral Surgery, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland

Received 24 April 2009; Revised 7 August 2009; Accepted 13 September 2009

Academic Editor: James L. Mulshine

Copyright © 2009 C. P. Martinelli-Kläy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. Whiteside, “Immunology of head and neck cancer,” Cancer Metastasis Reviews , vol. 24, pp. 95–105, 2005. View at Google Scholar
  2. E. A. Jacobsen, A. G. Taranova, N. A. Lee, and J. J. Lee, “Eosinophils: singularly destructive effector cells or purveyors of immunoregulation?” Journal of Allergy and Clinical Immunology, vol. 119, no. 6, pp. 1313–1320, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. Lotfi, J. J. Lee, and M. T. Lotze, “Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors,” Journal of Immunotherapy, vol. 30, no. 1, pp. 16–28, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. Kita, “The eosinophil: a cytokine-producing cell?” Journal of Allergy and Clinical Immunology, vol. 97, no. 4, pp. 889–892, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Rothenberg and S. P. Hogan, “The eosinophil,” Annual Review of Immunology, vol. 24, pp. 147–174, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. I. Ellyard, L. Simson, and C. R. Parish, “Th2-mediated anti-tumour immunity: friend or foe?” Tissue Antigens, vol. 70, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. R. G. Dorta, G. Landman, L. P. Kowalski, J. R. P. Lauris, M. R. D. O. Latorre, and D. T. Oliveira, “Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas,” Histopathology, vol. 41, no. 2, pp. 152–157, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Horiuchi, K. Mishima, M. Ohsawa, M. Sugimura, and K. Aozasa, “Prognostic factors for well-differentiated squamous cell carcinoma in the oral cavity with emphasis on immunohistochemical evaluation,” Journal of Surgical Oncology, vol. 53, no. 2, pp. 92–96, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Li, S. Sad, D. Kägi, and T. R. Mosmann, “CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions,” The Journal of Immunology, vol. 158, no. 9, pp. 4152–4161, 1997. View at Google Scholar · View at Scopus
  10. A.-L. Stenfeldt and C. Wennerås, “Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils,” Immunology, vol. 112, no. 4, pp. 605–614, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. S. A. Cormier, A. G. Taranova, C. Bedient et al., “Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response,” Journal of Leukocyte Biology, vol. 79, no. 6, pp. 1131–1139, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. T. Nishimura, K. Iwakabe, M. Sekimoto et al., “Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo,” The Journal of Experimental Medicine, vol. 190, no. 5, pp. 617–627, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. R. I. Tepper, P. K. Pattengale, and P. Leder, “Murine interleukin-4 displays potent anti-tumor activity in vivo,” Cell, vol. 57, no. 3, pp. 503–512, 1989. View at Google Scholar · View at Scopus
  14. R. I. Tepper, R. L. Coffman, and P. Leder, “An eosinophil-dependent mechanism for the antitumor effect of interleukin-4,” Science, vol. 257, no. 5069, pp. 548–551, 1992. View at Google Scholar · View at Scopus
  15. N. Zimmermann, G. K. Hershey, P. S. Foster, and M. E. Rothenberg, “Chemokines in asthma: cooperative interaction between chemokines and IL-13,” Journal of Allergy and Clinical Immunology, vol. 111, no. 2, pp. 227–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. M. Lorena, D. T. Oliveira, R. G. Dorta, G. Landman, and L. P. Kowalski, “Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia,” Oral Diseases, vol. 9, no. 6, pp. 279–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. O. V. Volpert, T. Fong, A. E. Koch et al., “Inhibition of angiogenesis by interleukin 4,” The Journal of Experimental Medicine, vol. 188, no. 6, pp. 1039–1046, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Simson, J. I. Ellyard, L. A. Dent et al., “Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance,” The Journal of Immunology, vol. 178, no. 7, pp. 4222–4229, 2007. View at Google Scholar · View at Scopus
  19. C. Conticello, F. Pedini, A. Zeuner et al., “Il-4 protects cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins,” The Journal of Immunology, vol. 172, no. 9, pp. 5467–5477, 2004. View at Google Scholar · View at Scopus
  20. H.-L. Ma, M. J. Whitters, B. A. Jacobson, D. D. Donaldson, M. Collins, and K. Dunussi-Joannopoulos, “Tumor cells secreting IL-13 but not IL-13Rα2 fusion protein have reduced tumorigenicity in vivo,” International Immunology, vol. 16, no. 7, pp. 1009–1017, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. Terabe, S. Matsui, N. Noben-Trauth et al., “NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway,” Nature Immunology, vol. 1, no. 6, pp. 515–520, 2000. View at Google Scholar · View at Scopus
  22. H.-Z. Shi, “Eosinophils function as antigen-presenting cells,” Journal of Leukocyte Biology, vol. 76, no. 3, pp. 520–527, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. U. M. Padigel, J. J. Lee, T. J. Nolan, G. A. Schad, and D. Abraham, “Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis,” Infection and Immunity, vol. 74, no. 6, pp. 3232–3238, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. Y.-J. Jung, S.-Y. Woo, M. H. Jang et al., “Human eosinophils show chemotaxis to lymphoid chemokines and exhibit antigen-presenting-cell-like properties upon stimulation with IFN-γ, IL-3 and GM-CSF,” International Archives of Allergy and Immunology, vol. 146, no. 3, pp. 227–234, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. D. Mawhorter, J. W. Kazura, and W. H. Boom, “Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation,” Immunology, vol. 81, no. 4, pp. 584–591, 1994. View at Google Scholar · View at Scopus
  26. L. S. van Rijt, N. Vos, D. Hijdra, V. C. de Vries, H. C. Hoogsteden, and B. N. Lambrecht, “Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells,” The Journal of Immunology, vol. 171, no. 7, pp. 3372–3378, 2003. View at Google Scholar · View at Scopus
  27. J. J. Oppenheim and D. Yang, “Alarmins: chemotactic activators of immune responses,” Current Opinion in Immunology, vol. 17, no. 4, pp. 359–365, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. D. Yang, Q. Chen, S. B. Su et al., “Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses,” The Journal of Experimental Medicine, vol. 205, no. 1, pp. 79–90, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. L.-Y. Liu, S. K. Mathur, J. B. Sedgwick, N. N. Jarjour, W. W. Busse, and E. A. B. Kelly, “Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 61, no. 5, pp. 589–597, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. B. Lamkhioued, A. S. Gounni, D. Aldebert et al., “Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils,” Annals of the New York Academy of Sciences, vol. 796, pp. 203–208, 1996. View at Google Scholar · View at Scopus
  31. M. Grewe, W. Czech, A. Morita et al., “Human eosinophils produce biologically active IL-12: implications for control of T cell responses,” The Journal of Immunology, vol. 161, no. 1, pp. 415–420, 1998. View at Google Scholar · View at Scopus
  32. D. M. Mosser and X. Zhang, “Interleukin-10: new perspectives on an old cytokine,” Immunological Reviews, vol. 226, no. 1, pp. 205–218, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. D. H. Munn and A. L. Mellor, “Indoleamine 2,3-dioxygenase and tumor-induced tolerance,” The Journal of Clinical Investigation, vol. 117, no. 5, pp. 1147–1154, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. S. O. Odemuyiwa, A. Ghahary, Y. Li et al., “Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase,” The Journal of Immunology, vol. 173, no. 10, pp. 5909–5913, 2004. View at Google Scholar · View at Scopus
  35. S. Astigiano, B. Morandi, R. Costa et al., “Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer,” Neoplasia, vol. 7, no. 4, pp. 390–396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Puxeddu, D. Ribatti, E. Crivellato, and F. Levi-Schaffer, “Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases,” Journal of Allergy and Clinical Immunology, vol. 116, no. 3, pp. 531–536, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. Tian and W. P. Schiemann, “The TGFβ paradox in human cancer: an update,” Future Oncology, vol. 5, no. 2, pp. 259–271, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. M. L. van Herpen, J. A. W. M. van der Laak, I. J. M. Vries et al., “Intratumoral recombinant humam interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor,” Clinical Cancer Research, vol. 11, pp. 1899–1909, 2005. View at Google Scholar
  39. S. Dasgupta, M. Bhattacharya-Chatterjee, B. W. O'Malley Jr., and S. K. Chatterjee, “Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma,” Molecular Therapy, vol. 13, no. 1, pp. 183–192, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. A. Agarwal, M. Rani, G. K. Saha, T. M. Valarmathi, S. Bahadur, B. K. Mohanti et al., “Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma,” Immunological Investigations, vol. 32, no. 1-2, pp. 17–30, 2003. View at Google Scholar · View at Scopus
  41. C. Jiang, D. Ye, W. Qiu et al., “Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO,” BMC Cancer, vol. 7, pp. 40–49, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. N. Horie, T. Shimoyama, T. Kaneko, and F. Ide, “Multiple oral squamous cell carcinomas with blood and tissue eosinophila,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 8, pp. 1648–1650, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. P. Manchanda, S. C. Sharma, and S. N. Das, “Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma,” Oral Diseases, vol. 12, no. 5, pp. 455–462, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. R. Walter, H. I. Joller-Jemelka, and F. Salomon, “Metastatic squamous cell carcinoma with marked blood eosinophilia and elevated serum interleukin-5 levels,” Experimental Hematology, vol. 30, no. 1, pp. 1–2, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Sato, R. Kobayashi, M. Nakajima, A. Iguchi, and T. Ariga, “Significance of eosinophilia after stem cell transplantation as a possible prognostic marker for favorable outcome,” Bone Marrow Transplantation, vol. 36, no. 11, pp. 985–991, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. H. Yamazaki, T. Inoue, E. Tanaka et al., “Pelvic irradiation-induced eosinophilia is correlated to prognosis of cervical cancer patients and transient elevation of serum interleukin 5 level,” Radiation Medicine, vol. 23, no. 5, pp. 317–321, 2005. View at Google Scholar · View at Scopus
  47. M. J. Fernández-Aceñero, M. Galindo-Gallego, J. Sanz, and A. Aljama, “Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma,” Cancer, vol. 88, no. 7, pp. 1544–1548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. D. S. Kapp and V. A. LiVolsi, “Intense eosinophilic stromal infiltration in carcinoma of the uterine cervix: a clinicopathologic study of 14 cases,” Gynecologic Oncology, vol. 16, no. 1, pp. 19–30, 1983. View at Google Scholar · View at Scopus
  49. A. Cuschieri, I. C. Talbot, and S. Weeden, “Influence of pathological tumour variables on long-term survival in resectable gastric cancer,” British Journal of Cancer, vol. 86, no. 5, pp. 674–679, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. T. P. Pretlow, E. F. Keith, A. K. Cryar et al., “Eosinophil infiltration of human colonic carcinomas as a prognostic indicator,” Cancer Research, vol. 43, no. 6, pp. 2997–3000, 1983. View at Google Scholar · View at Scopus
  51. G. W. Spiegel, M. Ashraf, and J. J. S. Brooks, “Eosinophils as a marker for invasion in cervical squamous neoplastic lesions,” International Journal of Gynecological Pathology, vol. 21, no. 2, pp. 117–124, 2002. View at Google Scholar · View at Scopus
  52. P. J. F. Quaedvlieg, D. H. K. V. Creytens, G. G. Epping et al., “Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips,” Histopathology, vol. 49, no. 3, pp. 256–264, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. S. Agarwal, N. Wadhwa, and G. Gupta, “Eosinophils as a marker for invasion in cervical squamous neoplastic lesions,” International Journal of Gynecological Pathology, vol. 22, no. 2, p. 213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. A. A. Tadbir, M. J. Ashraf, and Y. Sardari, “Prognostic significance of stromal eosinophilic infiltration in oral squamous cell carcinoma,” Journal of Craniofacial Surgery, vol. 20, no. 2, pp. 287–289, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. M. M. Goldsmith, D. H. Cresson, and F. B. Askin, “The prognostic significance of stromal eosinophilia in head and neck cancer,” Otolaryngology—Head and Neck Surgery, vol. 96, no. 4, pp. 319–324, 1987. View at Google Scholar · View at Scopus
  56. S. E. Leighton, J. G. Teo, S. F. Leung, A. Y. Cheung, J. C. Lee, and C. A. van Hasselt, “Prevalence and prognostic significance of tumour-associated tissue eosinophilia in nasopharyngeal carcinoma,” Cancer, vol. 77, no. 3, pp. 436–440, 1996. View at Publisher · View at Google Scholar
  57. S. J. Alrawi, D. Tan, D. L. Stoler et al., “Tissue eosinophilic infiltration: a useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia,” Cancer Journal, vol. 11, no. 3, pp. 217–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Said, S. Wiseman, J. Yang et al., “Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms,” BMC Clinical Pathology, vol. 5, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. A. M. Sassler, K. D. McClatchey, G. T. Wolf, and S. G. Fisher, “Eosinophilic infiltration in advanced laryngeal squamous cell carcinoma,” Laryngoscope, vol. 105, no. 4, pp. 413–416, 1995. View at Google Scholar · View at Scopus
  60. D. Lowe and C. D. M. Fletcher, “Eosinophilia in squamous cell carcinoma of the oral cavity, external genitalia and anus-clinical correlations,” Histopathology, vol. 8, no. 4, pp. 627–632, 1984. View at Google Scholar · View at Scopus
  61. G. Falconieri, M. A. Luna, S. Pizzolitto, G. DeMaglio, V. Angione, and M. Rocco, “Eosinophil-rich squamous carcinoma of the oral cavity: a study of 13 cases and delineation of a possible new microscopic entity,” Annals of Diagnostic Pathology, vol. 12, no. 5, pp. 322–327, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. M. M. Goldsmith, D. A. Belchis, D. H. Cresson, W. D. Merritt III, and F. B. Askin, “The importance of the eosinophil in head and neck cancer,” Otolaryngology—Head and Neck Surgery, vol. 106, no. 1, pp. 27–33, 1992. View at Google Scholar · View at Scopus
  63. I. Ercan, B. Çakir, T. Başak, T. Özdemir, I. Sayin, and S. Turgut, “Prognostic significance of stromal eosinophilic infiltration in cancer of the larynx,” Otolaryngology—Head and Neck Surgery, vol. 132, no. 6, pp. 869–873, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. D. T. W. Wong, S. M. Bowen, A. Elovic, G. T. Gallagher, and P. F. Weller, “Eosinophil ablation and tumor development,” Oral Oncology, vol. 35, no. 5, pp. 496–501, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. D. T. Oliveira, K. C. Tjioe, A. Assao et al., “Tissue eosinophilia and its association with tumoral invasion of oral cancer,” International Journal of Surgical Pathology, vol. 17, no. 3, pp. 244–249, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. J. O. Alkhabuli and A. S. High, “Significance of eosinophil counting in tumor associated tissue eosinophilia (TATE),” Oral Oncology, vol. 42, no. 8, pp. 849–850, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus